EMBLEM Technology Transfer
EMBLEM Technology Transfer GmbH is the exclusive technology transfer subsidiary of the European Molecular Biology Laboratory (EMBL), commercializing a portfolio of 1,000+ inventions and 450+ patents from EMBL research via licensing, services, software distribution, and spin-off formation across global life sciences markets.
- Company typePrivate
- Founded1999
- HeadquartersHeidelberg, Germany
- Headcount11–50
- GTM typeB2B
- OfferingServices
What EMBLEM Technology Transfer does
EMBLEM Technology Transfer GmbH (legally EMBL Enterprise Management Technology Transfer GmbH) is the wholly owned subsidiary and exclusive technology and knowledge transfer arm of the European Molecular Biology Laboratory (EMBL), founded in 1999 and headquartered in Heidelberg, Germany. The company identifies, protects, and commercializes intellectual property generated by EMBL's scientists, alumni, and select third parties, administering a portfolio of more than 1,000 inventions and over 450 patents/copyrights across life sciences sectors including structural biology, genomics, imaging, bioinformatics, drug discovery, and agriculture.
EMBLEM's commercial surface spans four revenue streams: (1) negotiated licensing of EMBL-developed technologies and patents to pharmaceutical, biotechnology, and agricultural companies; (2) molecular biology services and consultancy provided by EMBL scientists; (3) research collaborations with industry partners; and (4) an EMBLEM Software Store that distributes ~20 EMBL-developed scientific tools (e.g., ATSAS for SAXS/SANS analysis, ARP/wARP for protein refinement, FOLD-X for stability prediction, STRING for protein interaction networks, JLib for instrument control) to academic and commercial users globally. The firm also co-founds and supports spin-off companies such as TimeTeller (chronobiology diagnostics), Luvida (AI-driven clinical trial design), Cerelixis (agricultural phytostimulants), and DenovAI (AI antibody discovery).
The company's go-to-market is sales-led and relationship-driven, executed through direct industry outreach, EMBL partnership referrals, entrepreneurial programming (e.g., "From Lab to Launch" events), and ecosystem alliances including Heidelberg Startup Partners, BioInnovation Institute, AION Labs, and the Israel Innovation Authority. Pricing is custom-negotiated on multi-year contracts with no publicly disclosed rates. EMBLEM's customer base spans global pharma/biotech enterprises, public-sector institutions (e.g., NHS Scotland using PopPIPE for AMR surveillance), and early-stage startups operating in life sciences verticals.
EMBLEM Technology Transfer firmographics
Firmographics- Name
- EMBLEM Technology Transfer
- Legal name
- EMBL Enterprise Management Technology Transfer GmbH
- Website
- https://embl-em.de
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- EMBLEM Technology Transfer GmbH is the exclusive technology transfer subsidiary of the European Molecular Biology Laboratory (EMBL), commercializing a portfolio of 1,000+ inventions and 450+ patents from EMBL research via licensing, services, software distribution, and spin-off formation across global life sciences markets.
- Ownership category
- akta.pro rank
EMBLEM Technology Transfer industry classification
Industry- Product category
- Technology Transfer Services
- NAICS
- Management, Scientific, and Technical Consulting Services (5416), Software Publishers (513210)
- SIC
- Patent Owners & Lessors (6794), Miscellaneous Publishing (2741)
- akta.pro primary industry
- IP Licensing, Transactions & Technology Transfer (BPAHAMAF)
- akta.pro secondary industry
- Knowledge Management & Scientific Collaboration / Literature Intelligence (HLAGAJAN)
Keywords
Where EMBLEM Technology Transfer is headquartered
LocationHeadquarters
- HQ city
- Heidelberg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
EMBLEM Technology Transfer business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Technology Licensing: EMBLEM offers licenses to an extensive portfolio of technologies from various sectors of life sciences. Licensing fees are negotiated for access to EMBL-developed technologies and patents.
- Molecular Biology Services: Provision of state-of-the-art molecular biology services to industry partners and clients requiring access to EMBL expertise and facilities.
- Research Collaborations: Consultancy by EMBL scientists and research collaborations with external organizations seeking to leverage EMBL's scientific expertise.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom licensing agreements |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
EMBLEM Technology Transfer product offering
Product offeringCore offering
EMBLEM Technology Transfer GmbH identifies, protects, and commercializes intellectual property developed at the European Molecular Biology Laboratory (EMBL). The company manages a portfolio of more than 1,000 inventions and over 450 patents/copyrights, licensing life sciences technologies to industry partners and providing access to molecular biology services, consultancy by EMBL scientists, and research collaborations. EMBLEM also distributes a suite of scientific software tools (structural biology, bioinformatics, microscopy, and systems biology applications) through its own software store and supports the creation of spin-off companies based on EMBL research.
Product overview
EMBLEM Technology Transfer operates a software store distributing scientific software products developed from EMBL research. The portfolio includes structural biology tools (C3D, ARP/wARP, ATSAS, FOLD-X, Agadir, InterPreTs, PolyPhen, TANGO, ViCi), systems biology tools (SmartCell, STRING), bioinformatics resources (SMART, SNPeffect), microscopy and instrument control software (AutoFocusScreen for ZEN, Micropilot, JLib, StaubCom), and cloud services (Embassy Cloud). These products serve academic and commercial users in life sciences research, drug discovery, and structural biology. EMBLEM also manages a portfolio of over 1000 inventions and 450+ patents from EMBL scientists, providing technology transfer and licensing services to industry.
Differentiator
Problem solved
Functional benefit
Brands
- EMBLEM Software Store: A software distribution platform offering EMBL-developed scientific software tools for structural analysis, imaging, instrument control, protein-function analysis, and systems biology.
- INNOVATION WORKS®
Products and services
- Technology Licensing Licensing of an extensive portfolio of life sciences technologies and patents developed at EMBL, negotiated on a case-by-case basis for access to proprietary inventions by pharmaceutical, biotechnology, and life sciences companies.
- Molecular Biology Services State-of-the-art molecular biology services provided to industry partners and clients requiring access to EMBL expertise, facilities, and instrumentation.
- Research Collaborations and Consultancy Consultancy by EMBL scientists and structured research collaborations with external organizations seeking to leverage EMBL's scientific expertise in molecular biology and life sciences.
- Spin-off Company Creation and Support Co-founding and supporting startup companies based on EMBL technologies, including TimeTeller, Luvida, Cerelixis, and DenovAI, providing path to market for research innovations.
- C3D Crystal centering software that automatically locates a crystal and its holder for centering on a goniometer spindle and alignment with an X-ray beam, featuring improved handling of difficult situations like highly transparent crystals.
- Agadir Prediction algorithm based on helix/coil transition theory that predicts the helical behaviour of monomeric peptides, considering short range interactions with parameters for pH, temperature and ionic strength.
- ARP/wARP Automated Refinement Procedure program package for protein structure refinement that combines iterative reciprocal space structure factor refinement with real space model updating.
- ATSAS Program suite for small angle scattering (SAXS/SANS) data analysis and modelling used to study the structure of biological macromolecules in solution.
- FOLD-X Algorithm providing fast and quantitative estimation of interactions contributing to protein stability and for calculating folding pathways of proteins and protein complexes.
- InterPreTs Program to test putative interactions on complexes of known 3D structure determined by experimental structural biology methods such as X-ray crystallography.
- PolyPhen Tool that predicts possible impact of amino acid substitution on the structure and function of human proteins using empirical rules applied to sequence, structure and conservation analysis.
- TANGO Software that predicts protein aggregation based on a statistical mechanics algorithm based on physico-chemical principles of beta-sheet formation.
- ViCi In silico ligand-based drug design software employing shape matching methodologies combined with tools for describing atomic makeup and electrostatic distribution of molecules.
- SmartCell Framework for modelling and simulation of diffusion-reaction networks in a whole-cell context, supporting localisation and diffusion of molecules.
- Embassy Cloud Service enabling data analysis activities alongside EBI public datasets in a secure, private virtual datacenter with flexible configuration.
- AutoFocusScreen for ZEN VBA macro for intuitive setup of complex time-lapse and multiposition experiments on Zeiss confocal microscopes.
- Micropilot Microscopy software that can be rapidly trained to identify cells of interest automatically and automate complex fluorescence microscopy-based imaging assays.
- SMART Simple Modular Architecture Research Tool for identification and annotation of genetically mobile domains and analysis of domain architectures in signaling, extracellular and chromatin-associated proteins.
- SNPeffect
Quantifiable outcome
- 721% increase in polygenic risk scores hosted in PGS Catalog since 2021
- +2 more outcomes
Companies that use EMBLEM Technology Transfer
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
EMBLEM Technology Transfer technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
EMBLEM Technology Transfer partnerships and signals
Strategic signalPartnerships
14 partnerships are on record, tiered major and core.
- Instruct-ERICmajorEuropean research infrastructure providing access to instruments like EasyGrid and EasyGrid Control for the scientific community. Instruct-ERIC coordinates access to high-end technologies for structural biology research.
- NHS Lothian and University of St AndrewsmajorCollaboration using PopPIPE genomic analysis tool to investigate antibiotic-resistant bacterial infections across hospital wards, revealing transmission clusters and supporting outbreak response.
- Heidelberg Startup Partners e.V.majorAssociation of research and educational organizations from the Heidelberg area including EMBLEM, Technologiepark Heidelberg, and IHK Rhein-Neckar. Provides advice to inventors, founders and young companies, personal consultation in founders' office, seminars, events, access to coach network, and help with business modelling and funding.
- European Molecular Biology Laboratory (EMBL)coreEMBL Enterprise Management Technology Transfer GmbH is the wholly owned subsidiary and exclusive technology and knowledge transfer partner of EMBL. EMBLEM manages the commercialization of EMBL's research output, including over 1000 inventions and 450+ patents/copyrights.
- EMBL Crocker Research GroupcoreResearch collaboration on agrochemical effects on insect populations using EMBL's unique chemical library of 1000+ agrochemicals for large-scale screens on fruit flies, mosquitoes, and butterflies.
- AION LabsmajorIsrael-based innovation model that created DenovAI startup. AION Labs identifies industry R&D challenges, recruits scientist founders, and supports startup formation with backing from Pfizer, AstraZeneca, Merck, Teva, AWS, Israel Innovation Authority, and Israel Biotech Fund.
- EMBL Grenoble Instrumentation TeamcoreCollaboration on EasyGrid development including researchers from EMBL sites with expertise in structural and cell biology (Grenoble, Hamburg, Heidelberg) and partner institutes in France (Inserm, Institut Pasteur, Sorbonne Université, IAB).
- EMBL Imaging CentremajorEMBL IC in Heidelberg received EasyGrid and EasyGrid Control prototypes, integrating these platforms to provide researchers with control over sample vitrification parameters and high-throughput screening capabilities.
- Heidelberg UniversitymajorCollaboration on deep brain imaging research using three-photon microscopy technique enhanced with AI to track glioblastoma tumor cells, involving neuroscientists, neurooncologists, and AI experts.
- EMBL-EBIcoreDevelopment and maintenance of the Polygenic Score (PGS) Catalog, the largest open database for polygenic scores with ~27,000 users from over 140 countries. Collaboration with University of Cambridge and GWAS Catalog.
- DESY Start-up OfficemajorJoint organizer of 'From Lab to Launch' science entrepreneurship event focused on funding pathways for science-based start-ups, bringing together scientists, entrepreneurs, and innovation professionals.
- Helmholtz-Zentrum HereonmajorJoint organizer of 'From Lab to Launch' science entrepreneurship event supporting technology transfer and startup ecosystem development.
- BioInnovation Institute (BII)majorCerelixis, the EMBL spin-off developing precision phytostimulants, was selected for BII's prestigious Venture Lab Programme in Copenhagen, receiving funding, facilities, mentorship, and access to life science innovation ecosystem.
- Israel Innovation AuthoritymajorPartnership providing technology transfer program including grants, terms and conditions for Israeli companies seeking to access EMBL technologies and collaboration opportunities.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
EMBLEM Technology Transfer competitors and assessment
Company assessmentDirect peers
- Cambridge Enterprise: Technology transfer office of the University of Cambridge. Directly comparable as an academic TTO with a deep life sciences portfolio, active spin-out creation, and significant licensing income.
- CNRS Innovation: The technology transfer subsidiary of France's CNRS. Directly comparable as a European public-research TTO managing patent portfolios, licensing, and spin-off support across the life sciences and physical sciences.
- Oxford University Innovation: Technology transfer office of the University of Oxford. Directly comparable as an academic TTO with a strong life sciences licensing and spin-out formation franchise, including notable biotech exits.
- LifeArc: UK-based medical research charity and tech transfer organization previously known as MRC Technology. Directly comparable as a life sciences-focused technology transfer and spin-out creation entity operating across academic research.
- Max Planck Innovation: The technology transfer office of the Max Planck Society, performing an identical role to EMBLEM but for the Max Planck Institutes. Directly comparable as a German academic TTO licensing life sciences and physics inventions and supporting spin-offs.
- Ascenion: Technology transfer partner for the Helmholtz Center Munich and life science institutes. Directly comparable as a German life sciences TTO managing invention portfolios, licensing, and spin-off formation.
- Institut Pasteur – Pasteur+: Commercial subsidiary of the Institut Pasteur focused on technology transfer and industrial partnerships. Directly comparable as a European research-institute TTO in life sciences.
Others
- EMBL Ventures: Venture capital firm investing in EMBL-affiliated life sciences companies. Related to EMBLEM and explicitly listed as a 'Related Organisation' on EMBLEM's site, but operates as an investor rather than a tech transfer office.
- BioInnovation Institute (BII): Life sciences innovation hub in Copenhagen that supports EMBL spin-offs (e.g., Cerelixis) through its Venture Lab program. Adjacent as an incubator/accelerator providing funding and facilities to EMBL-derived startups.
Broad incumbents
- Fraunhofer: Germany's largest applied research organization with extensive licensing and spin-out activity. A broader incumbent operating at much greater scale across multiple disciplines, but with overlapping life sciences and biotech technology transfer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
EMBLEM Technology Transfer social profiles
Digital presenceEMBLEM Technology Transfer financial estimates
Financial estimateRevenue estimate
Valuation estimate
EMBLEM Technology Transfer leadership team
Management profileNumber of profiles
Profiles5 records
EMBLEM Technology Transfer funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
EMBLEM Technology Transfer M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about EMBLEM Technology Transfer
What does EMBLEM Technology Transfer do?
EMBLEM Technology Transfer GmbH identifies, protects, and commercializes intellectual property developed at the European Molecular Biology Laboratory (EMBL). The company manages a portfolio of more than 1,000 inventions and over 450 patents/copyrights, licensing life sciences technologies to industry partners and providing access to molecular biology services, consultancy by EMBL scientists, and research collaborations. EMBLEM also distributes a suite of scientific software tools (structural biology, bioinformatics, microscopy, and systems biology applications) through its own software store and supports the creation of spin-off companies based on EMBL research.
Is EMBLEM Technology Transfer a public or private company?
EMBLEM Technology Transfer is a private company. It is classified as corporate owned and is currently operating.
When was EMBLEM Technology Transfer founded?
EMBLEM Technology Transfer was founded in 1999. It employs 11 to 50 people.
Where is EMBLEM Technology Transfer based?
EMBLEM Technology Transfer is headquartered in Heidelberg, Germany, in the Europe region.
How does EMBLEM Technology Transfer make money?
Three revenue lines are on record. Technology Licensing is the primary driver. The others are molecular Biology Services and research Collaborations.
Who are EMBLEM Technology Transfer's main competitors?
Direct peers on record are Cambridge Enterprise, CNRS Innovation, Oxford University Innovation, LifeArc, Max Planck Innovation, Ascenion and Institut Pasteur – Pasteur+. Others are EMBL Ventures and BioInnovation Institute (BII). Fraunhofer is listed as a broad incumbent.
Does EMBLEM Technology Transfer have an API?
No public API is recorded for EMBLEM Technology Transfer.
What industry is EMBLEM Technology Transfer in?
EMBLEM Technology Transfer's product category is Technology Transfer Services. Its primary akta.pro industry code is BPAHAMAF, IP Licensing, Transactions & Technology Transfer, with a secondary code of HLAGAJAN, Knowledge Management & Scientific Collaboration / Literature Intelligence. Its NAICS code is 5416 and its SIC code is 6794.